We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+22.16%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$204M
AUM Growth
+$41.2M
(+25%)
Cap. Flow
+$34M
Cap. Flow
% of AUM
16.72%
Top 10 Holdings %
Top 10 Hldgs %
64.81%
Holding
152
New
50
Increased
18
Reduced
29
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MACOM Technology Solutions
MTSI
|
+$2.29M |
| 2 |
Coherent
COHR
|
+$2.02M |
| 3 |
MaxLinear
MXL
|
+$1.84M |
| 4 |
Everspin Technologies
MRAM
|
+$1.32M |
| 5 |
OBCI
Ocean Bio-Chem Inc
OBCI
|
+$1.21M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dropbox
DBX
|
+$1.91M |
| 2 |
EGIO
Edgio, Inc. Common Stock
EGIO
|
+$1.85M |
| 3 |
BFX
BowFlex Inc.
BFX
|
+$1.53M |
| 4 |
WIFI
Boingo Wireless, Inc.
WIFI
|
+$871K |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$771K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.48% |
| 2 | Healthcare | 6.98% |
| 3 | Consumer Discretionary | 2.55% |
| 4 | Consumer Staples | 1.24% |
| 5 | Real Estate | 1.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Gyre Therapeutics
GYRE
$648M
| $751K | 0.37% |
17,064
-158
| -0.9% | -$7.42K |
|
27
A10 Networks
ATEN
$2.16B
| $735K | 0.36% |
107,926
+29,336
| +37% | +$197K |
|
|
SBBP
28
DELISTED
Strongbridge Biopharma plc.
SBBP
| $700K | 0.34% |
+185,153
| New | +$555K |
|
29
Booking.com
BKNG
$150B
| $699K | 0.34% |
+10,975
| New | +$668K |
|
30
State Street Health Care Select Sector SPDR ETF
XLV
$42.2B
| $683K | 0.34% |
6,828
-396
| -5% | -$39.1K |
|
31
Imunon
IMNN
$6.72M
| $664K | 0.33% |
+912
| New | +$395K |
|
|
PXD
32
DELISTED
Pioneer Natural Resource Co.
PXD
| $659K | 0.32% |
+6,751
| New | +$595K |
|
33
TechTarget
TTGT
$325M
| $649K | 0.32% |
21,623
-285
| -1% | -$7.19K |
|
34
CALL
Ross Stores
ROST
$81B
| $627K | 0.31% |
42,100
+22,600
| +116% | +$2.05M |
|
|
BDSI
35
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $626K | 0.31% |
143,676
-1,874
| -1% | -$8.42K |
|
|
ADMS
36
DELISTED
Adamas Pharmaceuticals
ADMS
| $624K | 0.31% |
243,706
+86,564
| +55% | +$254K |
|
|
DSPG
37
DELISTED
DSP Group Inc
DSPG
| $613K | 0.3% |
38,608
-23,623
| -38% | -$387K |
|
38
Annovis Bio
ANVS
$75.3M
| $607K | 0.3% |
139,617
-4,133
| -3% | -$17.1K |
|
|
CVM.WS
39
PUT
DELISTED
Cel-Sci Corp Series S
CVM.WS
| $604K | 0.3% |
+246,100
| New | +$604K |
|
|
EMKR
40
DELISTED
Emcore Corp
EMKR
| $590K | 0.29% |
+18,528
| New | +$524K |
|
41
PUT
iShares S&P 100 ETF
OEF
$19.9B
| $586K | 0.29% |
+76,500
| New | +$10.3M |
|
42
Pixelworks
PXLW
$37.4M
| $569K | 0.28% |
14,668
-8,702
| -37% | -$376K |
|
43
PUT
Norwegian Cruise Line
NCLH
$8.59B
| $567K | 0.28% |
+180,100
| New | +$2.64M |
|
44
Argan
AGX
$8.13B
| $564K | 0.28% |
9,013
-1,314
| -13% | -$50.2K |
|
45
Marriott Vacations Worldwide
VAC
$3.35B
| $555K | 0.27% |
+6,746
| New | +$549K |
|
46
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $550K | 0.27% |
4,915
-2,129
| -30% | -$210K |
|
|
ACER
47
DELISTED
Acer Therapeutics Inc
ACER
| $544K | 0.27% |
+158,787
| New | +$448K |
|
48
Energy Focus
EFOI
$19.8M
| $530K | 0.26% |
+10,929
| New | +$279K |
|
49
Cellectar Biosciences
CLRB
$20.2M
| $511K | 0.25% |
+1,330
| New | +$558K |
|
50
CALL
O'Reilly Automotive
ORLY
$72.4B
| $474K | 0.23% |
+1,380,000
| New | +$36.1M |
|
Similar funds
VL
WTG
SP
OGC
PE
RL
AIIC
LGM
Worth Venture Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Worth Venture Partners held 152 positions worth $204M, up 25% from $162M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Worth Venture Partners deployed $34M of net new capital in Q2 2020, opening 50 new positions and adding to 18 existing holdings. Its largest new stake was MACOM Technology Solutions: 78,540 shares worth $2.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 8% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was BowFlex Inc., an estimated $1.53M trimmed.
- Worth Venture Partners's largest Q2 2020 buy was MACOM Technology Solutions: 78,540 shares worth $2.7M.
- Worth Venture Partners added most to scPharmaceuticals in Q2 2020, an estimated $280K increase.
- Worth Venture Partners's biggest Q2 2020 reduction was BowFlex Inc., cutting an estimated $1.53M.
- Worth Venture Partners fully exited Dropbox in Q2 2020, selling an estimated $1.91M.
- Worth Venture Partners's ten largest holdings make up 65% of its $204M portfolio in Q2 2020.
- Worth Venture Partners opened 50 new positions and closed 35 in Q2 2020.
- Worth Venture Partners's portfolio value rose 25% quarter-over-quarter to $204M.
Based on Worth Venture Partners's 13F filing for Q2 2020, filed 14 Aug 2020.